Presentation TCT 2013 Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada) Presenter: Marian Hawkey October 29, 2013
Presentation TCT 2013 An Overview of Patient Risk Stratification in Patients Enrolled in the CoreValve US Extreme Risk Study Presenter: Thomas Gleason October 29, 2013
Presentation TCT 2013 A Critical Analysis of Functional Improvement after TAVR in the CoreValve US Extreme Risk Study Presenter: David Cohen October 29, 2013
Presentation TCT 2013 Yes! The Multicenter Registry Data Are Compelling Presenter: Nicolas van Mieghem October 28, 2013
Presentation TCT 2013 When Do I Prefer Transcarotid Vascular Access for TAVR? Presenter: Vinod Thourani October 28, 2013
Presentation TCT 2013 Valvular Heart Disease: Aortic Valvuloplasty and TAVR Presenter: Anita Asgar October 28, 2013
Presentation TCT 2013 Transcaval Access for TAVR: An Exciting New Alternative in Selected Patients Presenter: Adam Greenbaum October 28, 2013
Presentation TCT 2013 Transcatheter Based Aortic Valve Replacement using Tissue Engineered Heart Valves: Preclinical Experiences Presenter: Simon Hoerstrup October 28, 2013
Presentation TCT 2013 The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR) Presenter: Philippe Généreux October 28, 2013
Presentation TCT 2013 The Case for a Hybrid OR-Cath Lab for TAVR Procedures Presenter: Alan Lumsden October 28, 2013
Presentation TCT 2013 Technology Review and Clinical Results(6) Presenter: Raj Makkar October 28, 2013
Presentation TCT 2013 Technology Review and Clinical Results(5) Presenter: John Webb October 28, 2013
Presentation TCT 2013 Technology Review and Clinical Results(4) Presenter: Ganesh Manoharan October 28, 2013